Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-29

FDA Approved: GLIMEPIRIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original application for glimepiride (Rising Pharma Holdings, Inc.), a generic medication for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

ORIG AP for GLIMEPIRIDE (GLIMEPIRIDE)